ZIMLABUpdated 1 Sept 2026, 23:21

Zim Laboratories Limited

ZIMLABUpdated 1 Sept 2026, 23:21

Market Cap

₹628Cr.

Current Price

₹118

High / Low

₹134/59.3

Stock P/E

166

ROE1.66%

ROCE4.91%

Book Value₹53.5

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1989, Zim LaboratoriesLtd manufactures formulation drugs andpre formulation ingredients in India andmarkets and sells these within and outside India[1]

Quarterly results

Last reported quarters₹ Cr.

Profit & loss

Annual statement₹ Cr.

Shareholding pattern

As of Jun 2026%

Shareholding trend

Ownership over time%

Balance sheet

Assets & liabilities₹ Cr.

Cash flows

Operating, investing & financing₹ Cr.

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	111	120	137	119	99	84	77	90	81	100	91	91
Inventory Days	104	88	108	134	126	144	125	171	99	173	188	208
Days Payable	144	109	137	172	165	168	150	186	109	133	156	170
Cash Conversion Cycle	71	99	108	81	61	60	52	75	71	140	123	129
Working Capital Days	38	35	55	37	41	40	41	59	61	55	48	29
ROCE %	—	13%	14%	13%	15%	5%	10%	12%	17%	10%	8%	5%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 23:21

ZIM LABORATORIES LIMITED (ZIMLAB) financials — quarterly results, P&L, cash flow, balance sheet, shareholding